Status:

UNKNOWN

Deep Transcranial Magnetic Stimulation for the Treatment of Treatment Resistance Schizophrenia

Lead Sponsor:

Shanghai Mental Health Center

Conditions:

Deep Transcranial Magnetic Stimulation for the Treatment of Treatment Resistance Schizophrenia

Eligibility:

All Genders

18-60 years

Phase:

NA

Brief Summary

Based on the hypothesis that low-frequency deep transcranial magnetic stimulation(dTMS) on anterior cingulate cortex (ACC) could down-regulate the glutamate level of ACC and regulate the acc-related f...

Detailed Description

This study includes 20 treatment resistance schizophrenia patients and 20 healthy controls.This study will investigate 1)abnormalities of the glutamate level of ACC in patients with schizophrenia comp...

Eligibility Criteria

Inclusion

  • Patients with schizophrenia who meet the dsm-5 diagnostic criteria
  • Aged from 18 to 60
  • After 4 weeks of treatment with a sufficient dose of an antipsychotic (equivalent dose of 400 \~ 600 mg/ day chlorpromazine (CPZ)), no clinical improvement was achieved (at least two items in PANSS scale P1,P2,P3,N1,N4,N6,G5 and G9 ≥4 points, or cgi-s ≥4 points)
  • Right-handedness, normal hearing, visual acuity or corrected visual acuity
  • Written informed consent of the patient and his/her family

Exclusion

  • Patients who are currently taking clozapine or who have failed to respond to a full course of treatment with clozapine
  • Current or past neurological illness,severe physical illness,substance abuse or addiction,alcohol dependence,mental retardation,pregnancy or lactation,extreme agitation, stupor, negative suicide,or those who can not cooperate
  • A history of MECT within 6 months,or those with contraindications to MRI,rTMS
  • Medically unstable for at least 1 month (PANSS score fluctuation\>10%)

Key Trial Info

Start Date :

July 5 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 30 2022

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04478032

Start Date

July 5 2020

End Date

December 30 2022

Last Update

September 14 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shanghai Mental Health Center

Shanghai, Shanghai Municipality, China, 200030

Deep Transcranial Magnetic Stimulation for the Treatment of Treatment Resistance Schizophrenia | DecenTrialz